0:00
/
0:00
Transcript

Trispecific Antibodies, Design Approaches, Mechanism of action, Antibody Engineering

Luke McLaughlin, Biotech Digital Marketer, Business Developer and Life Science Content Creator

Trispecific antibodies represent an innovative class of biotherapeutic agents designed to engage multiple therapeutic targets simultaneously. By combining the binding specificities of three different antibodies into a single molecule, trispecific antibodies can orchestrate complex biological responses, offering a multifaceted approach to treating diseases, particularly cancer and autoimmune disorders. This overview will delve into the design, mechanism of action, applications, advantages, challenges, and future prospects of trispecific antibodies. This podcast episode covers all details and aspects of their design Approaches and Mechanism of action.

Discussion about this video